| 000 | 01783 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516145257.0 | ||
| 264 | 0 | _c20140117 | |
| 008 | 201401s 0 0 eng d | ||
| 022 | _a1349-6867 | ||
| 024 | 7 |
_a10.2152/jmi.60.77 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYuasa, Shino | |
| 245 | 0 | 0 |
_aTreatment responses and their predictors in patients with rheumatoid arthritis treated with biological agents. _h[electronic resource] |
| 260 |
_bThe journal of medical investigation : JMI _c2013 |
||
| 300 |
_a77-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdalimumab |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xblood |
| 650 | 0 | 4 |
_aC-Reactive Protein _xanalysis |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xtherapeutic use |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xtherapeutic use |
| 700 | 1 | _aYamaguchi, Harutaka | |
| 700 | 1 | _aNakanishi, Yoshinori | |
| 700 | 1 | _aKawaminami, Shingo | |
| 700 | 1 | _aTabata, Ryo | |
| 700 | 1 | _aShimizu, Nobuhiko | |
| 700 | 1 | _aKohno, Mitsuhiro | |
| 700 | 1 | _aShimizu, Teruki | |
| 700 | 1 | _aMiyata, Junya | |
| 700 | 1 | _aNakayama, Mayuko | |
| 700 | 1 | _aKishi, Jun | |
| 700 | 1 | _aToyoda, Yuko | |
| 700 | 1 | _aNishioka, Yasuhiko | |
| 700 | 1 | _aTani, Kenji | |
| 773 | 0 |
_tThe journal of medical investigation : JMI _gvol. 60 _gno. 1-2 _gp. 77-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2152/jmi.60.77 _zAvailable from publisher's website |
| 999 |
_c22697034 _d22697034 |
||